Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q3 2019 · 10-Q
Revenue$0.00$0.00— vs Q3 2018 Net Income-$1.78M-$1.78MN/M vs Q3 2018 EPS Diluted-$0.01-$0.01N/M vs Q3 2018 Operating Income-$1,574,001N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Sep 30, 2019 · filed Oct 28, 2019 · 28 d after period end